Stay informed about the latest diabetes news and research, including medical discoveries, treatment developments, clinical studies, technology and emerging health insights.
An endocrinologist says people with diabetes need not give up desserts entirely, but should tailor choices to their condition, monitor portions and consider lower-sugar alternatives. Endocrinologist Pavel Baranov says sweets are not automatically off the menu for people with diabetes,…
With diabetes rising and retinal disease becoming harder to predict, Australian optometrists are being urged to combine more comprehensive imaging with closer monitoring of glucose changes, pregnancy and other high-risk factors. Diabetic retinopathy remains one of the most important preventable…
A breakthrough in Toronto in 1922 transformed type 1 diabetes from an often fatal diagnosis into a condition that could be managed, after James Collip helped purify the treatment for human use. By 1922, a breakthrough in Toronto had begun…
Doctors may consider anti-obesity medicines sooner than many patients expect, but side effects, long-term use and high costs remain significant barriers. Obesity remains a major long-term health problem, and the World Health Organization says the global burden has continued to…
Income, education, gender and geography continue to influence exposure to risk factors and access to screening, diagnosis and treatment, according to a new WHO report. The World Health Organization has warned that inequality continues to shape who develops non-communicable diseases…
Diabetes Canada chief executive Laura Syron’s experience highlights the difficult balance between visibility, privacy and fears of being judged less capable at work. Laura Syron says leading a national diabetes charity while living with type 2 diabetes has meant learning…
Viking Therapeutics is testing whether a redesigned dosing plan can overcome earlier side effects as it advances tablet and injectable versions of its obesity drug VK2735. Viking Therapeutics has given investors another reason to focus on its obesity pipeline after…
The first CVRM Professional Care conference has called for joined-up, person-centred treatment to replace isolated management of heart, kidney and metabolic conditions. At the first CVRM Professional Care conference, Kevin Fernando argued that cardiovascular, renal and metabolic medicine needs to…
Semaglutide can lower blood sugar and body weight, but evidence of cardiovascular protection is broadening its role beyond weight loss and highlighting the importance of careful long-term monitoring. Semaglutide began as a treatment for type 2 diabetes, but its wider…
A multicentre study found that more than one-third of Vietnamese adults with type 2 diabetes had advanced cardiovascular-kidney-metabolic risk, while blood pressure and lipid targets remained out of reach for many. A multicentre Vietnamese study published by Wiley adds to…
A review finds retinal scans work best when combined with clinical data, but small studies, inconsistent definitions and limited external validation are holding back clinical use. A systematic review published in the Wiley journal article suggests that deep learning models…
Health authorities say Apidra insulin is temporarily unavailable because of international supply constraints, while alternative rapid-acting products and other insulin classes remain accessible nationwide. Pakistan’s health ministry and the Drug Regulatory Authority of Pakistan have pushed back against reports of…
